A new study finds patients who had a lower copayment for a generic statin were not only more likely to take their medicine but they were also more likely to experience fewer deaths due to heart attack or stroke than those taking a brandname statin To wit patients on a generic statin had an  reduction in the rate of adverse outcomes And the difference in copayments was notable The average outofpocket cost to fill a prescription for a generic statin was  while a brandname cholesterol pill cost patients  As a result the lead study author says copays should be slashed or waived